Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 101 Pages
Report ld: 5503280
Request Sample
Customized Report
Pathogen Testing Market Size(US$)

CAGR 2026-2032
7.8%
Market Size,2032
USD 10,130
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pathogen Testing was estimated to be worth US$ 6033 million in 2025 and is projected to reach US$ 10130 million, growing at a CAGR of 7.8% from 2026 to 2032.
Global Pathogen Testing includes SGS SA, Eurofins Scientific, Institut Mérieux, etc. Global top three companies hold a share over 40%. Europe is the largest market, with a share about 26%, followed by North America and China with the share about 21% and 17%.
This report provides a comprehensive view of the global market for Pathogen Testing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Pathogen Testing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pathogen Testing.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Pathogen Testing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pathogen Testing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pathogen Testing revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pathogen Testing Product Introduction
1.2 Global Pathogen Testing Market Size Forecast (2021–2032)
1.3 Pathogen Testing Market Trends & Drivers
1.3.1 Pathogen Testing Industry Trends
1.3.2 Pathogen Testing Market Drivers & Opportunities
1.3.3 Pathogen Testing Market Challenges
1.3.4 Pathogen Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pathogen Testing Players Revenue Ranking (2025)
2.2 Global Pathogen Testing Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Pathogen Testing Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Pathogen Testing
2.6 Pathogen Testing Market Competitive Analysis
2.6.1 Pathogen Testing Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Pathogen Testing Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pathogen Testing revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Pathogen Testing Market Classification
3.1 Introduction by Type
3.1.1 PCR
3.1.2 LAMP
3.1.3 Global Pathogen Testing Sales Value by Type
3.1.3.1 Global Pathogen Testing Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Pathogen Testing Sales Value, by Type (2021–2032)
3.1.3.3 Global Pathogen Testing Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Industry
4.1.2 Laboratory
4.1.3 Others
4.2 Global Pathogen Testing Sales Value by Application
4.2.1 Global Pathogen Testing Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Pathogen Testing Sales Value by Application (2021–2032)
4.2.3 Global Pathogen Testing Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Pathogen Testing Sales Value by Region
5.1.1 Global Pathogen Testing Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Pathogen Testing Sales Value by Region (2021–2026)
5.1.3 Global Pathogen Testing Sales Value by Region (2027–2032)
5.1.4 Global Pathogen Testing Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Pathogen Testing Sales Value, 2021–2032
5.2.2 North America Pathogen Testing Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Pathogen Testing Sales Value, 2021–2032
5.3.2 Europe Pathogen Testing Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Pathogen Testing Sales Value, 2021–2032
5.4.2 Asia Pacific Pathogen Testing Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Pathogen Testing Sales Value, 2021–2032
5.5.2 South America Pathogen Testing Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pathogen Testing Sales Value, 2021–2032
5.6.2 Middle East & Africa Pathogen Testing Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pathogen Testing Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Pathogen Testing Sales Value, 2021–2032
6.3 United States
6.3.1 United States Pathogen Testing Sales Value, 2021–2032
6.3.2 United States Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Pathogen Testing Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Pathogen Testing Sales Value, 2021–2032
6.4.2 Europe Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Pathogen Testing Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Pathogen Testing Sales Value, 2021–2032
6.5.2 China Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.5.3 China Pathogen Testing Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Pathogen Testing Sales Value, 2021–2032
6.6.2 Japan Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Pathogen Testing Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Pathogen Testing Sales Value, 2021–2032
6.7.2 South Korea Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Pathogen Testing Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Pathogen Testing Sales Value, 2021–2032
6.8.2 Southeast Asia Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Pathogen Testing Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Pathogen Testing Sales Value, 2021–2032
6.9.2 India Pathogen Testing Sales Value by Type (%), 2025 vs 2032
6.9.3 India Pathogen Testing Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 SGS SA
7.1.1 SGS SA Profile
7.1.2 SGS SA Main Business
7.1.3 SGS SA Pathogen Testing Products, Services, and Solutions
7.1.4 SGS SA Pathogen Testing Revenue (US$ Million), 2021–2026
7.1.5 SGS SA Recent Developments
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Profile
7.2.2 Eurofins Scientific Main Business
7.2.3 Eurofins Scientific Pathogen Testing Products, Services, and Solutions
7.2.4 Eurofins Scientific Pathogen Testing Revenue (US$ Million), 2021–2026
7.2.5 Eurofins Scientific Recent Developments
7.3 Institut Mérieux
7.3.1 Institut Mérieux Profile
7.3.2 Institut Mérieux Main Business
7.3.3 Institut Mérieux Pathogen Testing Products, Services, and Solutions
7.3.4 Institut Mérieux Pathogen Testing Revenue (US$ Million), 2021–2026
7.3.5 Institut Mérieux Recent Developments
7.4 ALS Limited
7.4.1 ALS Limited Profile
7.4.2 ALS Limited Main Business
7.4.3 ALS Limited Pathogen Testing Products, Services, and Solutions
7.4.4 ALS Limited Pathogen Testing Revenue (US$ Million), 2021–2026
7.4.5 ALS Limited Recent Developments
7.5 Charles River
7.5.1 Charles River Profile
7.5.2 Charles River Main Business
7.5.3 Charles River Pathogen Testing Products, Services, and Solutions
7.5.4 Charles River Pathogen Testing Revenue (US$ Million), 2021–2026
7.5.5 Charles River Recent Developments
7.6 Intertek Group
7.6.1 Intertek Group Profile
7.6.2 Intertek Group Main Business
7.6.3 Intertek Group Pathogen Testing Products, Services, and Solutions
7.6.4 Intertek Group Pathogen Testing Revenue (US$ Million), 2021–2026
7.6.5 Intertek Group Recent Developments
7.7 Symbio Laboratories
7.7.1 Symbio Laboratories Profile
7.7.2 Symbio Laboratories Main Business
7.7.3 Symbio Laboratories Pathogen Testing Products, Services, and Solutions
7.7.4 Symbio Laboratories Pathogen Testing Revenue (US$ Million), 2021–2026
7.7.5 Symbio Laboratories Recent Developments
7.8 TUV Nord
7.8.1 TUV Nord Profile
7.8.2 TUV Nord Main Business
7.8.3 TUV Nord Pathogen Testing Products, Services, and Solutions
7.8.4 TUV Nord Pathogen Testing Revenue (US$ Million), 2021–2026
7.8.5 TUV Nord Recent Developments
7.9 FoodChain ID Group
7.9.1 FoodChain ID Group Profile
7.9.2 FoodChain ID Group Main Business
7.9.3 FoodChain ID Group Pathogen Testing Products, Services, and Solutions
7.9.4 FoodChain ID Group Pathogen Testing Revenue (US$ Million), 2021–2026
7.9.5 FoodChain ID Group Recent Developments
7.10 AsureQuality
7.10.1 AsureQuality Profile
7.10.2 AsureQuality Main Business
7.10.3 AsureQuality Pathogen Testing Products, Services, and Solutions
7.10.4 AsureQuality Pathogen Testing Revenue (US$ Million), 2021–2026
7.10.5 AsureQuality Recent Developments
7.11 Microbac Laboratories
7.11.1 Microbac Laboratories Profile
7.11.2 Microbac Laboratories Main Business
7.11.3 Microbac Laboratories Pathogen Testing Products, Services, and Solutions
7.11.4 Microbac Laboratories Pathogen Testing Revenue (US$ Million), 2021–2026
7.11.5 Microbac Laboratories Recent Developments
7.12 Guangdong IQTC
7.12.1 Guangdong IQTC Profile
7.12.2 Guangdong IQTC Main Business
7.12.3 Guangdong IQTC Pathogen Testing Products, Services, and Solutions
7.12.4 Guangdong IQTC Pathogen Testing Revenue (US$ Million), 2021–2026
7.12.5 Guangdong IQTC Recent Developments
7.13 IFP Institut für Produktqualität GmbH
7.13.1 IFP Institut für Produktqualität GmbH Profile
7.13.2 IFP Institut für Produktqualität GmbH Main Business
7.13.3 IFP Institut für Produktqualität GmbH Pathogen Testing Products, Services, and Solutions
7.13.4 IFP Institut für Produktqualität GmbH Pathogen Testing Revenue (US$ Million), 2021–2026
7.13.5 IFP Institut für Produktqualität GmbH Recent Developments
7.14 Vimta Labs
7.14.1 Vimta Labs Profile
7.14.2 Vimta Labs Main Business
7.14.3 Vimta Labs Pathogen Testing Products, Services, and Solutions
7.14.4 Vimta Labs Pathogen Testing Revenue (US$ Million), 2021–2026
7.14.5 Vimta Labs Recent Developments
8 Industry Chain Analysis
8.1 Pathogen Testing Value Chain
8.2 Pathogen Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Pathogen Testing Sales Model
8.5.2 Sales Channels
8.5.3 Pathogen Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pathogen Testing market size was US$ 6033 million in 2025 and is forecast to reach a readjusted size of US$ 10130 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 98
USD 4250.00
(Single User License)
The global Pathogen Testing market was valued at US$ 6033 million in 2025 and is anticipated to reach US$ 10130 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 111
USD 2900.00
(Single User License)
The global Pathogen Testing market size was US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
The global Pathogen Testing market is projected to grow from US$ 5637 million in 2024 to US$ 9467 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
The global market for Pathogen Testing was estimated to be worth US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 114
USD 3950.00
(Single User License)
The global market for Pathogen Testing was valued at US$ 5637 million in the year 2024 and is projected to reach a revised size of US$ 9467 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-19
Pages: 84
USD 2900.00
(Single User License)
The global market for Pathogen Testing was estimated to be worth US$ 4856.1 million in 2023 and is forecast to a readjusted size of US$ 8265.7 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
Published Date: 2024-01-18
Pages: 108
USD 3950.00
(Single User License)
The global Pathogen Testing market size was US$ 6033 million in 2025 and is forecast to reach a readjusted size of US$ 10130 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 98
The global Pathogen Testing market was valued at US$ 6033 million in 2025 and is anticipated to reach US$ 10130 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 111
The global Pathogen Testing market size was US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
The global Pathogen Testing market is projected to grow from US$ 5637 million in 2024 to US$ 9467 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 136
The global market for Pathogen Testing was estimated to be worth US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 114
The global market for Pathogen Testing was valued at US$ 5637 million in the year 2024 and is projected to reach a revised size of US$ 9467 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-19
Pages: 84
The global market for Pathogen Testing was estimated to be worth US$ 4856.1 million in 2023 and is forecast to a readjusted size of US$ 8265.7 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
Published: 2024-01-18
Pages: 108
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now